// Workers AI · dad joke modeWhat did MYBPH say to its date? You're my BP half.
| MYBPH | |||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Identifiers | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Aliases | MYBPH, myosin binding protein H | ||||||||||||||||||||||||||||||||||||||||||||||||||
| External IDs | OMIM: 160795; MGI: 1858196; HomoloGene: 3661; GeneCards: MYBPH; OMA:MYBPH - orthologs | ||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| Wikidata | |||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||
Myosin binding protein H (MYBPH) is a protein that in humans is encoded by the MYBPH gene. MYBPH is a structural muscle protein that shares sequence and structural similarities to myosin binding protein C (MyBPC) and is found mostly in skeletal muscle.[5][6]
Gene
[edit]Aliases
[edit]MYBPH is historically known as H-protein.
Location
[edit]The human MYBPH gene is on the long arm of chromosome 1 (1q32.1), contains eleven exons, and spans 11,404 base pairs (bp) on the minus strand.[7][8] It is immediately downstream of adenosine A1 receptor (ADORA1) and directly upstream of chitinase-3-like protein 1 (CHI3L1), as well as downstream of myogenin (MYOG) and upstream of chitinase (CHIT1).
Expression
[edit]MYBPH has low to moderate expression in a number of different tissues. The gene's expression is variable and ubiquitous amongst tissues, with the highest expression, in decreasing order, in skeletal muscle, the liver, placenta, trachea, and pancreas.
Transcript variants
[edit]In humans, MYBPH has two transcript variants, 1 and X1. While the main transcript variant has eleven exons, the alternative transcript variant contains an additional 5’ exon. Variant 1 is 1,818 nucleotides (nt) long and has 11 exons. Variant X1 is 3,921 nt long and contains 12 exons, differing from variant 1 in that it encodes a different N-terminus and utilizes a different promoter sequence.[8]
Protein
[edit]Isoforms
[edit]Human MYBPH's two transcript variants, 1 (477 amino acids (aa)) and X1 (518 aa), encode two protein isoforms, 1 and X1.[8] Isoform 1 of MYBPH has a calculated molecular weight of approximately 52 kDa. Isoform X1 has a calculated molecular weight of approximately 56.4 kDa.
| Isoform Number | Accession Number | mRNA Length (nt) | Protein Length (aa) | Molecular Weight (kDa) | Impact on Protein Produced |
| 1 | NM_004997.3[9] | 1,818 | 477 | 52 | Eleven exons |
| X1 | XM_047421205.1[10] | 3,921 | 518 | 56.4 | Twelve exons, different N-terminus encoded |
Domains
[edit]MYBPH has a UV excision repair protein Rad23 (Rad23) domain, two fibronectin type III (FN3) domains that also act as interdomain contacts [active] and cytokine receptor motifs [active], and two immunoglobulin (Ig and I-set) domains that each contain several Ig strands (B, C, E, F, G).[11]

The UV excision repair protein Rad23 (Rad23) domain targets nucleotide excision repair to specific parts of the genome.[12] Fibronectin type III (FN3) domain is an internal repeat found in fibronectin whose tenth repeat contains an Arginyl-Glycyl-Aspartic acid (RGD) cell recognition sequence.[12] Immunoglobulin (Ig) domains are a heterogenous group of proteins built on two beta sheets.[13]
Abundance
[edit]The MYBPH protein is less abundant than most other proteins in humans, as it falls under 1 ppm.[14] The protein's highest abundance in humans is in the skeletal muscle, following with the next highest in the esophagus.
Structure
[edit]
The tertiary ribbon structure of MYBPH shows the disordered region and Rad23 domain of the strand to be a stretched out, while the fibronectin type III (FN3) domains and immunoglobulin (Ig and I-set) domains of the strand are wrapped around themselves.[15]
Post-translational modifications
[edit]Phosphorylation and ubiquitylation
[edit]There are seven predicted phosphorylation sites and four predicted ubiquitylation sites in human MYBPH, which are also present in mouse and rat MYBPH proteins.[16]
C-mannosylation and O-GalNAc glycosylation
[edit]Human MYBPH is predicted to have seven C-mannosylation sites that are not heavily conserved in strict orthologs nor distant homologs.[17]
The protein is also predicted to have eleven O-GalNAc glycosylation sites that are not heavily conserved in strict orthologs nor distant homologs.[18]
Homology
[edit]Orthologs
[edit]


Fish are the most distantly related class to human MYBPH with the farthest median date of divergence being 429 million years ago. Whereas, mammalia is the closest related class to human MYBPH with the farthest median date of divergence being 87 million years ago. Reptilia, aves, and amphibia are moderately related to human MYBPH.
Paralogs
[edit]


Human MYBPH has eight paralogs. The closest related paralog is myosin binding protein H-like (MYBPHL) and the second closest related paralog is myosin binding protein C (MyBPC).
Evolution
[edit]MYBPH is estimated to have first appeared in fish approximately 429 million years ago. The protein is found in a variety of ray-finned fish and lobe-finned fish, but does not appear in cartilaginous fish. The most distantly related species compared to humans with MYBPH are lobe-finned fish. The protein is found only in vertebrates, as there are no proteins of the same identity in any invertebrates.[19]
The gene family consists of three genes, MYBPH and its paralogs MYBPHL and MyBPC. MYBPHL appears in ray-finned fish but not lobe-finned fish, while MyBPC appears in lobe-finned fish.
MYBPH is evolving more quickly than its paralogs (MYBPHL and MyBPC), cytochrome C, and fibrinogen complement factor 1.
Function
[edit]MYBPH contributes to sarcomere organization and striated muscle contraction. It is associated with the myosin filament and is active in the M band in sarcomeres. In muscle cells, MYBPH functions through binding-related activity and structural molecule activity to support the organization of the sarcomere.[5]
Interacting proteins
[edit]The protein found with the highest level of interaction with MYBPH is OCA2.[20] Each of the proteins found to interact with MYBPH do so by either textmining, direct interaction, or physical association.[21]
| Abbreviated Name | Full Name | Basis of Identification | Score | Confidence Value | Link | Description | Source |
| OCA2 | P Protein | Not listed | 0.996 | - | Textmining | Involved in the transport of tyrosine, the precursor to melanin synthesis, within the melanocyte. | STRING |
| GLDC | Glycine Dehydrogenase | Not listed | 0.994 | - | Textmining | Catalyzes the degradation of glycine. | STRING |
| SLAMF1 | Signaling Lymphocytic Activation Molecule | Not listed | 0.994 | - | Textmining | Self-ligand receptor of the signaling lymphocytic activation molecule (SLAM) family. | STRING |
| CD46 | Membrane Cofactor Protein | Not listed | 0.993 | - | Textmining | Acts as a cofactor for complement factor I. | STRING |
| NECTIN4 | Processed Poliovirus Receptor-Related Protein 4 | Not listed | 0.993 | - | Textmining | Involved in cell adhesion through trans-homophilic and -heterophilic interactions. | STRING |
| AMT | Aminomethyltransferase | Not listed | 0.984 | - | Textmining | Catalyzes the degradation of glycine. | STRING |
| GCSH | Glycine Cleavage System H Protein | Not listed | 0.957 | - | Textmining | Catalyzes the degradation of glycine. | STRING |
| C3 | Complement C3c Alpha Chain Fragment 1 | Not listed | 0.857 | - | Textmining | Plays a role in the activation of the complement system. | STRING |
| TLR2 | Toll-Like Receptor 2 | Not listed | 0.836 | - | Textmining | Works with LY96 to mediate the innate immune response to bacterial lipoproteins and other microbial cell wall components. | STRING |
| CFH | Complement Factor H | Not listed | 0.798 | - | Textmining | Glycoprotein that plays a role in maintaining a well-balanced immune response by modulating complement activation. | STRING |
| ROCK1 | Rho-Associated Coiled-Coil Containing Protein Kinase 1 | Pull down | - | 0.54 | Direct interaction | Regulates the shape, movement, and structural foundation of cells. | MINT - PSICQUIC |
| BAG3 | Bcl2 Associated Athanogene 3 | Affinity chromatography | - | 465 | Physical association | Regulates apoptosis, development, cell motility, autophagy, and tumor metastasis and mediates cell adaptive responses to stressful stimuli. | InnateDB - PSICQUIC |
| UBL7 | Ubiquitin-Like Protein SB132 | Two hybrid fragment pooling | - | 0.37 | Physical association | Regulator of protein homeostasis and innate immunity. | IMEx - PSICQUIC |
| CAPN3 | Calcium-Activated Neutral Proteinase 3 | Two hybrid fragment pooling | - | 0.37 | Physical association | Breaks down damaged proteins for removal, organizes muscle units, and regulates calcium levels essential for muscle contraction and relaxation. | IMEx - PSICQUIC |
Clinical significance
[edit]MYBPH was discovered in acting as a modifier of cardiac hypertrophy in hypertrophic cardiomyopathy (HCM) patients. It is shown to function in concert with cardiac myosin binding protein C (cMYBPC) in regulating cardiomyocyte contraction. There is a significant association between a MYBPH variant (rs2250509) and hypertrophy traits in one of the HCM-causing founder mutations (pA797T in β-myosin heavy chain gene (MYH7)).[22]
MYBPH is a transcriptional target of Thyroid Transcription Factor-1 (TTF-1) that inhibits assembly competence-conferring phosphorylation of the myosin regulatory light chain (RLC) and activates phosphorylation of LIM domain kinase (LIMK) through its interaction with Rho kinase 1 (ROCK1). MYBPH's interaction with ROCK1 inhibits the enzyme and negatively regulates actomyosin organization, reducing single cell motility and increasing collective cell migration that results in decreased cancer invasion and metastasis.[23]
References
[edit]- 1 2 3 GRCh38: Ensembl release 89: ENSG00000133055 – Ensembl, May 2017
- 1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000042451 – Ensembl, May 2017
- ↑ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ↑ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- 1 2 "MYBPH gene - Myosin Binding Protein H". GeneCards. 6 June 2026. Retrieved 6 June 2026.
- ↑ Mouton J, Loos B, Moolman-Smook JC, Kinnear CJ (February 2015). "Ascribing novel functions to the sarcomeric protein, myosin binding protein H (MyBPH) in cardiac sarcomere contraction". Experimental Cell Research. 331 (2): 338–351. doi:10.1016/j.yexcr.2014.11.006. PMID 25449695.
- ↑ "Genome Data Viewer - NCBI". www.ncbi.nlm.nih.gov. Retrieved 2026-06-04.
- 1 2 3 "MYBPH myosin binding protein H [Homo sapiens (human)] - Gene - NCBI". www.ncbi.nlm.nih.gov. Retrieved 2026-06-04.
- ↑ "Homo sapiens myosin binding protein H (MYBPH), mRNA". 2025-04-27.
- ↑ "PREDICTED: Homo sapiens myosin binding protein H (MYBPH), transcript variant X1, mRNA". 2025-08-05.
- ↑ "myosin-binding protein H isoform X1 [Homo sapiens] - Protein - NCBI". www.ncbi.nlm.nih.gov. Retrieved 2026-06-04.
- 1 2 NIH/NLM/NCBI/IEB/CDD group. "CDD Conserved Protein Domain Family: FN3". www.ncbi.nlm.nih.gov. Retrieved 2026-06-04.
- ↑ NIH/NLM/NCBI/IEB/CDD group. "CDD Conserved Protein Domain Family: Ig". www.ncbi.nlm.nih.gov. Retrieved 2026-06-04.
- ↑ "PaxDb: Protein Abundance Database". von Mering Lab, Swiss Institute of Bioinformatics, University of Zurich. Retrieved 2026-06-04.
- ↑ "iCn3D: Web-based 3D Structure Viewer". www.ncbi.nlm.nih.gov. Retrieved 2026-06-04.
- ↑ "MYBPH (human)". www.phosphosite.org. Retrieved 2026-06-04.
- ↑ "6A21B3710005EE6D22C26E0B expired". services.healthtech.dtu.dk. Retrieved 2026-06-04.
- ↑ "6A21B38C0005EEB111386DA3 expired". services.healthtech.dtu.dk. Retrieved 2026-06-04.
- ↑ "BLAST: Basic Local Alignment Search Tool". blast.ncbi.nlm.nih.gov. Retrieved 2026-06-04.
- ↑ "MYBPH protein (Human) - STRING interaction network". STRING. 2025. Retrieved 6 June 2026.
- ↑ PSICQUIC. "Psicquic View". www.ebi.ac.uk. Retrieved 2026-06-04.
- ↑ Mouton JM, van der Merwe L, Goosen A, Revera M, Brink PA, Moolman-Smook JC, et al. (May 2016). "MYBPH acts as modifier of cardiac hypertrophy in hypertrophic cardiomyopathy (HCM) patients". Human Genetics. 135 (5): 477–483. doi:10.1007/s00439-016-1649-7. PMID 26969327.
- ↑ Hosono Y, Yamaguchi T, Mizutani E, Yanagisawa K, Arima C, Tomida S, et al. (January 2012). "MYBPH, a transcriptional target of TTF-1, inhibits ROCK1, and reduces cell motility and metastasis". The EMBO Journal. 31 (2): 481–493. doi:10.1038/emboj.2011.416. PMC 3261566. PMID 22085929.